Assessment of a group-based comprehensive diabetes management program to improve glycemic control, quality of life and self-care behavior in patients with type 2 diabetes mellitus in a primary healthcare setting of a metropolitan city in India: CDMP MUM Trial
Background Resource-poor primary health settings in an urban slum presented with special challenges in diabetes care. The study evaluated a need-based, patient-friendly, acceptable, appropriate package of care and its implementation in primary healthcare setup. Material and Methods An open-label two-arm parallel randomized controlled trial with 40 patients in the control group who received medical management as prescribed by physician and patients in the intervention group receiving usual medical care + group-based comprehensive diabetes management program. HbA1c, weight, BMI, Quality of Life Instrument for Indian Diabetes Patients (QOLID) scores, and audit of Self Care Inventory-Revised Version (SCI-R) were assessed at baseline and 6 months. Result There was a significant reduction in mean HbA1c levels in the intervention arm (8.44, SD = 1.802 to 7.56, SD = 1.87) as compared with the control arm (8.4, SD = 1.87 to 8.19, SD = 1.77). Multiple linear regression model (R2 = 0.886, ANOVA F (7, 72) = 79.733, p < 0.001) found a fall in blood sugar levels (β = − 0.511, p < 0.001), improvement in QOLID scores (β = 0.221, p = 0.004), increase in physical activity (β = 0.198, p = 0.006), and fall in BMI (β = 0.153, p = 0.009) to be predictive of change in HbA1c. Discussion The patient profile consisted predominantly of homemakers, with low formal education and belonging to lower socio-economic strata. They depended primarily on the public health system for their health care needs and could benefit most from the implementation of the program. There was an improvement in knowledge, regular follow-up, compliance to medication, diet, and physical activity along with improvement in glycemic control, self-care behavior and quality of life of patients in the intervention arm..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:41 |
---|---|
Enthalten in: |
International journal of diabetes in developing countries - 41(2020), 1 vom: 06. Okt., Seite 156-163 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Baviskar, Mandar Padmakar [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
Themen: |
CDMP MUM |
---|
doi: |
10.1007/s13410-020-00828-1 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
SPR043435637 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | SPR043435637 | ||
003 | DE-627 | ||
005 | 20230519075926.0 | ||
007 | cr uuu---uuuuu | ||
008 | 210309s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s13410-020-00828-1 |2 doi | |
035 | |a (DE-627)SPR043435637 | ||
035 | |a (DE-599)SPRs13410-020-00828-1-e | ||
035 | |a (SPR)s13410-020-00828-1-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q ASE |
100 | 1 | |a Baviskar, Mandar Padmakar |e verfasserin |4 aut | |
245 | 1 | 0 | |a Assessment of a group-based comprehensive diabetes management program to improve glycemic control, quality of life and self-care behavior in patients with type 2 diabetes mellitus in a primary healthcare setting of a metropolitan city in India: CDMP MUM Trial |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Background Resource-poor primary health settings in an urban slum presented with special challenges in diabetes care. The study evaluated a need-based, patient-friendly, acceptable, appropriate package of care and its implementation in primary healthcare setup. Material and Methods An open-label two-arm parallel randomized controlled trial with 40 patients in the control group who received medical management as prescribed by physician and patients in the intervention group receiving usual medical care + group-based comprehensive diabetes management program. HbA1c, weight, BMI, Quality of Life Instrument for Indian Diabetes Patients (QOLID) scores, and audit of Self Care Inventory-Revised Version (SCI-R) were assessed at baseline and 6 months. Result There was a significant reduction in mean HbA1c levels in the intervention arm (8.44, SD = 1.802 to 7.56, SD = 1.87) as compared with the control arm (8.4, SD = 1.87 to 8.19, SD = 1.77). Multiple linear regression model (R2 = 0.886, ANOVA F (7, 72) = 79.733, p < 0.001) found a fall in blood sugar levels (β = − 0.511, p < 0.001), improvement in QOLID scores (β = 0.221, p = 0.004), increase in physical activity (β = 0.198, p = 0.006), and fall in BMI (β = 0.153, p = 0.009) to be predictive of change in HbA1c. Discussion The patient profile consisted predominantly of homemakers, with low formal education and belonging to lower socio-economic strata. They depended primarily on the public health system for their health care needs and could benefit most from the implementation of the program. There was an improvement in knowledge, regular follow-up, compliance to medication, diet, and physical activity along with improvement in glycemic control, self-care behavior and quality of life of patients in the intervention arm. | ||
650 | 4 | |a CDMP MUM |7 (dpeaa)DE-He213 | |
650 | 4 | |a Diabetes mellitus |7 (dpeaa)DE-He213 | |
650 | 4 | |a Urban slum |7 (dpeaa)DE-He213 | |
650 | 4 | |a Group-based comprehensive care |7 (dpeaa)DE-He213 | |
700 | 1 | |a Rangari, Sumitra |e verfasserin |4 aut | |
700 | 1 | |a Mishra, Sandeep |e verfasserin |4 aut | |
700 | 1 | |a Mohanta, Biswendu Sundar |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International journal of diabetes in developing countries |d [Delhi] : Springer India, 2006 |g 41(2020), 1 vom: 06. Okt., Seite 156-163 |w (DE-627)SPR03159963X |w (DE-600)2263351-0 |x 1998-3832 |7 nnns |
773 | 1 | 8 | |g volume:41 |g year:2020 |g number:1 |g day:06 |g month:10 |g pages:156-163 |
856 | 4 | 0 | |u https://dx.doi.org/10.1007/s13410-020-00828-1 |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_SPRINGER | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |d 41 |j 2020 |e 1 |b 06 |c 10 |h 156-163 |